Research Services

Obesity & Metabolic Health

De Novo Lipogenesis

Muscle Protein Synthesis

Glucose Kinetics

Energy Expenditure

Total Body Water

Amino Acid

Liver Health

De Novo Lipogenesis

Non-Invasive Breath Tests

Oncology

Cell Proliferation

Fibrosis Assessment

Fibrosis & Collagen Turnover

Rare Diseases & Gene Therapy

Urea Cycle Disorder

Rare Disease & Gene Therapy

End Product Nitrogen

Protein Turnover

Targeted Protein Half-life

Explore

Metabolic Solutions offers a broad spectrum of assays utilizing stable isotopes such as carbon-13 (¹³C), nitrogen-15 (¹⁵N), deuterium (²H), and oxygen-18 (¹⁸O).

Trusted by biomarker teams, clinical ops leaders, and pharma scientists who need validated, regulatory-ready isotope data.

Discover Our End-to-End Support
GI Breath Tests

For patients / consumers

Buy At Home Breath Tests

For healthcare providers

GI Breath Tests for Providers

Explore

We have developed and validated non-invasive breath tests that assess sugar intolerances and gastrointestinal health.

Built for GI clinics, hospitals, and any individual wanting to get tested for chronic stomach problems.
No prescription needed.

FAQ
Resources

Resources

Blog

Client List

Research Learning Center

GI Breath Tests Learning Center
About Us

About us

Accreditations

Quality Assurance

HIPAA Compliance

Good Laboratory Practices

Probiotic therapy alleviates SIBO but has no effect on liver disease

Researchers study use of probiotic therapy in patients with liver disease and SIBO

Oct 1, 2014 · 1 minute read

This research focused on the benefits of using probiotic therapy for patients with chronic liver disease, small intestinal bacterial overgrowth (SIBO) and intestinal permeability problems. The study enrolled 53 patients who consumed for 4 weeks a cocktail of 6 bacterial species. The result was that SIBO was resolved in many of the patients but intestinal permeability was not. This led the researchers to conclude that in liver disease patients’ probiotics are effective treatment for SIBO.

Ref: Eur J Gastroenterol Hepatol 2014 Sept 19

http://www.ncbi.nlm.nih.gov/pubmed/25244414

Other blogs you might like

Parkinson Disease and SIBO

Previous research has reported a high prevalence of small intestinal bacterial overgrowth in people with Parkinson’s Disease. A new study...

Read post

Probiotics treatment seems to improve leaky gut syndrome

New findings on shows that probiotics reduce zonulin levels.

Read post

New study shows that eradicating H. pylori is becoming more difficult

New study shows problems in eradicating H. pylori.

Read post

Back to all blog posts

Metabolic Solutions offers a broad spectrum of assays utilizing stable isotopes such as carbon-13 (¹³C), nitrogen-15 (¹⁵N), deuterium (²H), and oxygen-18 (¹⁸O).

We have developed and validated non-invasive breath tests that assess sugar intolerances and gastrointestinal health.

Probiotic therapy alleviates SIBO but has no effect on liver disease

Other blogs you might like

Parkinson Disease and SIBO

Probiotics treatment seems to improve leaky gut syndrome

New study shows that eradicating H. pylori is becoming more difficult

Contact us

Research Services

GI Breath Tests

About Metabolic Solutions

Metabolic Solutions offers a broad spectrum of assays utilizing stable isotopes such as carbon-13 (13C), nitrogen-15 (15N), deuterium (2H), and oxygen-18 (18O).

We have developed and validated non-invasive breath tests that assess sugar intolerances and gastrointestinal health.

Probiotic therapy alleviates SIBO but has no effect on liver disease

Other blogs you might like

Parkinson Disease and SIBO

Probiotics treatment seems to improve leaky gut syndrome

New study shows that eradicating H. pylori is becoming more difficult

Get notified on new research technologies

Contact us

Research Services

GI Breath Tests

About Metabolic Solutions

Metabolic Solutions offers a broad spectrum of assays utilizing stable isotopes such as carbon-13 (¹³C), nitrogen-15 (¹⁵N), deuterium (²H), and oxygen-18 (¹⁸O).